Full profile

Also known asCholecalciferol
Best forFoundational nutritional support · Correcting or preventing low vitamin D status · Northern-latitude, low-sun populations
Evidence gradeGrade C — Limited — early or small human trials
Studied dose range1,000–2,000 IU (25–50 mcg) daily for maintenance; up to the 4,000 IU (100 mcg) adult upper limit under guidance. Canadian non-prescription monograph routes cap lower — see label tips.
Time to effectNot acute; serum levels rise over roughly 6–12 weeks of daily use.
Best formD3 (cholecalciferol) over D2; take with a fat-containing meal for absorption.
Food sourcesFatty fish (salmon, mackerel, sardines), Cod liver oil, Egg yolks, UV-exposed mushrooms, Fortified milk and plant milks

Evidence, honestly graded

For its own roles (bone, calcium, immune) the evidence is strong, but for cognition specifically it is weak: a 24-trial meta-analysis found only a small global-cognition effect concentrated in deficient groups, and RCTs in replete healthy adults show no cognitive benefit. Graded C for the cognition angle only.

See the full grading rubric — study type, replication, population match, and dose adequacy — in The Evidence Standard.

Side effects

  • Very well tolerated at supplemental doses
  • Toxicity is rare and only at chronic high intakes (hypercalcemia)

Who should avoid it or check first

  • Hypercalcemia, hyperparathyroidism, or sarcoidosis
  • Kidney stones or significant renal impairment
  • Known vitamin D hypersensitivity

Interactions

  • May interact with thiazide diuretics, high-dose calcium, and digoxin — discuss with a clinician

Stacks well with

  • Phosphatidylserine
  • Citicoline
  • Bacopa Monnieri

Use caution stacking with

  • Avoid high combined doses with separate calcium supplements without review

What to look for on a label

  • State both IU and micrograms (e.g. "1,000 IU (25 mcg)") since labels increasingly lead with mcg.
  • Respect the 4,000 IU (100 mcg) adult upper limit and add a "do not exceed" statement.

References

  • Chen 2024, Neuropsychology Review — meta-analysis (24 RCTs). Small global-cognition effect across 24 RCTs / 7,557 people, concentrated in deficient groups. PMID 37418225; doi:10.1007/s11065-023-09598-z. Educational, not a product claim.
  • Health Canada NNHPD Vitamin D monograph. Permits bone/immune/good-health claims, not cognition. webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/1175. Confirm current version (NHP monographs updated effective 2026-03-27) before filing.

Primary citations for some entries above are still being compiled; those without a linked identifier are editorial summaries of the wider literature.

Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.

See how Vitamin D3 compares on grade, dose, and goal in the Evidence Explorer.